Containing midazolam or its salts
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other: > Other > Other: > Medicaments primarily affecting the central nervous system: > Anticonvulsants, hypnotics and sedatives: > Containing midazolam or its salts
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3004.90.92.38
Midazolam Hydrochloride 1mg/mL Injectable Solution
This sterile injectable solution contains midazolam hydrochloride at 1mg/mL concentration, put up in pre-filled 2mL syringes for single-dose administration. It is used primarily as a sedative for procedural sedation and preoperative anxiolysis in therapeutic settings. Classified under HTS 3004.90.92.38 due to its midazolam content in measured doses for central nervous system effects as an anticonvulsant, hypnotic, or sedative.
Midazolam 5mg/mL IV Vial
A 5mg/mL midazolam injection in 10mL glass vials designed for intravenous use in emergency sedation or status epilepticus treatment. It consists of midazolam hydrochloride mixed with diluents for precise therapeutic dosing. Falls under HTS 3004.90.92.38 as a mixed product containing midazolam salts for sedative and anticonvulsant purposes.
Midazolam Oral Syrup 2mg/5mL
Pediatric oral syrup formulation of midazolam at 2mg per 5mL dose, in amber glass bottles with calibrated droppers for accurate prophylactic or therapeutic sedation. Used for seizure clusters or pre-procedure calming in children. HTS 3004.90.92.38 applies for its midazolam salt content in retail-ready measured doses affecting the CNS.
Midazolam Intranasal Spray 5mg
Single-use intranasal spray delivering 5mg midazolam per dose for rapid seizure termination in outpatient settings. Packaged in metered-dose nasal applicators for prophylactic epilepsy management. Classified in HTS 3004.90.92.38 for transdermal-like administration systems containing midazolam salts as hypnotics/sedatives.
Midazolam HCl Prefilled Syringe 2mg/2mL
Prefilled safety syringe with 2mg midazolam HCl in 2mL for hospital use in conscious sedation during endoscopy. Designed for single measured dose with needle shield. HTS 3004.90.92.38 due to midazolam salt in therapeutic CNS-affecting form for retail or institutional sale.
Midazolam 10mg Lyophilized Powder Vial
Freeze-dried midazolam powder equivalent to 10mg base in vials for reconstitution prior to IV injection in ICU sedation protocols. Supplied with diluent in measured kits for prophylactic use. Under HTS 3004.90.92.38 as a mixed/unmixed product containing midazolam salts in dosed form for sedatives.
Midazolam Buccal Film 7.5mg
Dissolvable buccal film strips containing 7.5mg midazolam for at-home seizure rescue therapy. Individually foil-wrapped for precise dosing in prophylactic anticonvulsant use. HTS 3004.90.92.38 for transdermal administration system with midazolam targeting CNS sedation.
Midazolam HCl 1mg Tablet Sublingual
Sublingual dissolvable tablets of 1mg midazolam HCl for rapid anxiolytic effect in dental procedures. Blister-packed in measured doses for retail pharmacy sale. Classified HTS 3004.90.92.38 for hypnotic/sedative midazolam salts in oral form.
Midazolam Pediatric Rectal Gel 5mg
Rectal gel applicator with 5mg midazolam for pediatric seizure control, pre-measured for home administration. Sterile, single-use packaging for prophylactic therapy. HTS 3004.90.92.38 as CNS sedative containing midazolam salts.
Midazolam Infusion Bag 50mg/50mL
Ready-to-use IV infusion bag containing 50mg midazolam in 50mL for continuous sedation in ventilated patients. PVC-free bag with measured volume for therapeutic use. Under HTS 3004.90.92.38 for mixed midazolam sedative in dosed form.